Improving classification of psychoses

The Lancet Psychiatry

Volumn 3, Issue 4, 2016, Pages 367-374

  Lawrie, Stephen M ^a   O'Donovan, Michael C ^b   Saks, Elyn ^c   Burns, Tom ^d   Lieberman, Jeffrey A ^e  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); DISEASE CLASSIFICATION; HUMAN; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; REVIEW; STAGING; CLASSIFICATION; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY;

HUMANS; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84962477432     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00577-5     Document Type: Review

References (70)

1. Evans K, McGrath J, Milns R Searching for schizophrenia in ancient Greek and Roman literature: a systematic review. Acta Psychiatr Scand 2003, 107:323-330.
2. Murphy JM Psychiatric labeling in cross-cultural perspective. Science 1976, 191:1019-1028.
3. Kraepelin E Lehrbuch der Psychiatrie 1896, Barth, Leipzig.
4. Bleuler E Dementia Praecox, or the Group of Schizophrenias 1911, International University Press, New York.
5. Schizophrenia: a multinational study 1975, WHO, World Health Organization, Geneva.
6. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972, 26:57-63.
7. Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Association, APA, Washington. fifth edition.
8. The ICD-10 classification of mental and behavioural disorders 1992, WHO, World Health Organization, Geneva.
9. Perälä J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007, 64:19-28.
10. Kessler RC, Birnbaum H, Demler O, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry 2005, 58:668-676.
11. Kendell RE The role of diagnosis in psychiatry 1975, Blackwell, Oxford.
12. Lai MC, Lombardo MV, Baron-Cohen S Autism. Lancet 2014, 383:896-910.
13. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F Borderline personality disorder. Lancet 2011, 377:74-84.
14. Seedat S, Stein MB, Oosthuizen PP, Emsley RA, Stein DJ Linking posttraumatic stress disorder and psychosis: a look at epidemiology, phenomenology, and treatment. J Nerv Ment Dis 2003, 191:675-681.
15. Braakman MH, Kortmann FA, van den Brink W Validity of 'post-traumatic stress disorder with secondary psychotic features': a review of the evidence. Acta Psychiatr Scand 2009, 119:15-24.
16. Carpenter WT, Strauss JS, Muleh S Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry 1973, 28:847-852.
17. Brockington IF, Kendell RE, Wainwright S, Hillier VF, Walker J The distinction between the affective psychoses and schizophrenia. Br J Psychiatry 1979, 135:243-248.
18. Peralta V, Cuesta MJ Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br J Psychiatry 1999, 174:243-248.
19. Kendell RE, Brockington IF, Leff JP Prognostic implications of six alternative definitions of schizophrenia. Arch Gen Psychiatry 1979, 36:25-31.
20. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992, 20:1-97.
21. Perkins DO, Gu H, Boteva K, Lieberman JA Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005, 162:1785-1804.
22. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005, 62:975-983.
23. Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014, 205:88-94.
24. Farooq S, Large M, Nielssen O, Waheed W The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis. Schizophr Res 2009, 109:15-23.
25. Tandon R, Gaebel W, Barch DM, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res 2013, 150:3-10.
26. Soares-Weiser K, Maayan N, Bergman H, et al. First rank symptoms for schizophrenia. Cochrane Database Syst Rev 2015, 1. CD010653.
27. Johnstone EC, Crow TJ, Frith CD, Owens DG The Northwick Park "functional" psychosis study: diagnosis and treatment response. Lancet 1988, 2:119-125.
28. Goodwin GM Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009, 23:346-388. the Consensus Group of the British Association for Psychopharmacology.
29. Wijkstra J, Lijmer J, Burger H, Geddes J, Nolen WA Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2013, 11. CD004044.
30. Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011, 37:811-821.
31. Mestdagh A, Hansen B Stigma in patients with schizophrenia receiving community mental health care: a review of qualitative studies. Soc Psychiatry Psychiatr Epidemiol 2014, 49:79-87.
32. Gerlinger G, Hauser M, De Hert M, Lacluyse K, Wampers M, Correll CU Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions. World Psychiatry 2013, 12:155-164.
33. Corlett PR, Fletcher PC Computational psychiatry: a Rosetta Stone linking the brain to mental illness. Lancet Psychiatry 2014, 1:399-402.
34. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the comprehensive assessment of at risk mental states. Aust N Z J Psychiatry 2005, 39:964-971.
35. Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkötter J Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 2010, 36:182-191.
36. McGhie A, Chapman J Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961, 34:103-116.
37. Howes OD, Lim S, Theologos G, Yung AR, Goodwin GM, McGuire P A comprehensive review and model of putative prodromal features of bipolar affective disorder. Psychol Med 2011, 41:1567-1577.
38. Large MM, Nielssen O Violence in first-episode psychosis: a systematic review and meta-analysis. Schizophr Res 2011, 125:209-220.
39. Silove D, Bateman CR, Brooks RT, et al. Estimating clinically relevant mental disorders in a rural and an urban setting in postconflict Timor Leste. Arch Gen Psychiatry 2008, 65:1205-1212.
40. Lieberman JA, First MB Renaming schizophrenia. BMJ 2007, 334:108.
41. Judge AM, Estroff SE, Perkins DO, Penn DL Recognizing and responding to early psychosis: a qualitative analysis of individual narratives. Psychiatr Serv 2008, 59:96-99.
42. Pitt L, Kilbride M, Welford M, Nothard S, Morrison AP Impact of a diagnosis of psychosis: user-led qualitative study. Psychiatr Bull 2009, 33:419-423.
43. Saks ER The centre cannot hold: my journey through madness 2007, Hyperion, New York.
44. Howe L, Tickle A, Brown I 'Schizophrenia is a dirty word': service users' experiences of receiving a diagnosis of schizophrenia. Psychiatr Bull (2014) 2014, 38:154-158.
45. Zangrilli A, Ducci G, Bandinelli PL, Dooley J, McCabe R, Priebe S How do psychiatrists address delusions in first meetings in acute care? A qualitative study. BMC Psychiatry 2014, 14:178.
46. Menezes NM, Arenovich T, Zipursky RB A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 2006, 36:1349-1362.
47. van Os J, Kapur S Schizophrenia. Lancet 2009, 374:635-645.
48. Maj M Critique of the DSM-IV operational diagnostic criteria for schizophrenia. Br J Psychiatry 1998, 172:458-460.
49. Grube BS, Bilder RM, Goldman RS Meta-analysis of symptom factors in schizophrenia. Schizophr Res 1998, 31:113-120.
50. Jablensky A, Hugler H, Von Cranach M, Kalinov K Kraepelin revisited: a reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908. Psychol Med 1993, 23:843-858.
51. Derks EM, Allardyce J, Boks MP, Vermunt JK, Hijman R, Ophoff RA Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls. Schizophr Bull 2012, 38:495-505. the GROUP.
52. Strauss JS Hallucinations and delusions as points on continua function. Rating scale evidence. Arch Gen Psychiatry 1969, 21:581-586.
53. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009, 39:179-195.
54. Linscott RJ, van Os J Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. Annu Rev Clin Psychol 2010, 6:391-419.
55. Cuthbert BN, Insel TR Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013, 11:126.
56. Buckholtz JW, Meyer-Lindenberg A Psychopathology and the human connectome: toward a transdiagnostic model of risk for mental illness. Neuron 2012, 74:990-1004.
57. McGorry P, Keshavan M, Goldstone S, et al. Biomarkers and clinical staging in psychiatry. World Psychiatry 2014, 13:211-223.
58. Kupfer DJ, Frank E, Ritchey FC Staging bipolar disorder: what data and what models are needed?. Lancet Psychiatry 2015, 2:564-570.
59. Lawrie SM, Hall J, McIntosh AM, Owens DG, Johnstone EC The 'continuum of psychosis': scientifically unproven and clinically impractical. Br J Psychiatry 2010, 197:423-425.
60. Deary IJ Intelligence. Annu Rev Psychol 2012, 63:453-482.
61. Lawrie SM, Olabi B, Hall J, McIntosh AM Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?. World Psychiatry 2011, 10:19-31.
62. Furukawa TA, Levine SZ, Tanaka S, et al. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry 2015, 72:14-21.
63. Johnstone EC, Frith CD, Crow TJ, et al. The Northwick Park 'Functional' Psychosis Study: diagnosis and outcome. Psychol Med 1992, 22:331-346.
64. Kotov R, Leong SH, Mojtabai R, et al. Boundaries of schizoaffective disorder: revisiting Kraepelin. JAMA Psychiatry 2013, 70:1276-1286.
65. Lawrie SM Clinical risk prediction in schizophrenia. Lancet Psychiatry 2014, 1:406-408.
66. Perlis RH A clinical risk stratification tool for predicting treatment resistance in major depressive disorder. Biol Psychiatry 2013, 74:7-14.
67. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427. Schizophrenia Working Group of the Psychiatric Genomics Consortium.
68. Lee SH, Ripke S, Neale BM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45:984-994. the Cross-Disorder Group of the Psychiatric Genomics Consortium, the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC).
69. Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012, 69:776-786.
70. Barch DM, Bustillo J, Gaebel W, et al. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res 2013, 150:15-20.